Qualigen Therapeutics Inc (NASDAQ:QLGN) I think this stock will post a sharp rally from current levels following the earnings report on Friday after-hours. The company announced a revenue increase of 30% from last year and cash equivalents approximately $21.9 Million, providing sufficient runway to accomplish Key Inflection Points (no offerings needed). This was a $4.43 stock in February and at $1.6, in my opinion, there is a compelling risk/reward scenario. The farther the fall the greater the chance for reversal. Lets keep an eye on it